Skip to main content
. 2015 Jun 4;2(3):283–285. doi: 10.1002/mdc3.12167

Table 1.

Treatment summary

Patient 1 Patient 2 Patient 3 Patient 4
Gender M M M F
Age of PD diagnosis 59 45 57 45
Initial DA medication Pramipexolea
Ropinirolea
Pramipexole 3 mg/day Ropinirole 8 mg/day Pramipexolea
Duration on DA <1 year 10 months 5 years 2 months
Type of ICD Hypersexual Hypersexual Hypersexual Compulsive buyingb
Compulsive cleaning
(Compulsive drinking)
Age of ICD onset 66 46 62 45b; 49
Treatment trials
DA reduction/cessation attempted Yes Yes Yes
l‐dopa reduction attempted Yes Yes Yes
SSRI Sertraline 100 mg/day
SNRI Venlafaxine XR 225 mg/day Venlafaxine 150 mg/day
Antipsychotic Quetiapine 50 mg/day Quetiapine 25 mg/day Quetiapine 12.5 mg/day
Other Amantadine 300 mg/day Amantadine 200 mg/day Amantadine 200 mg/day
Clozapine maximum dose 37.5 mg 37.5 mg 12.5 mg 25 mg
Follow‐up duration of sustained resolution 6 months 1 year 1 month 15 months
Side effect Sedation Weight gain
a

Dosing unknown.

b

Initial ICD, responded to dopamine agonist cessation.

SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin‐noradrenaline (norepinephrine) reuptake inhibitor.